Status: Recruiting
HEALEY ALS Platform Trial - Master Protocol
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
Participants needed: 1,500
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Merit E. Cudkowicz, MDUpdated: Jun 4, 2026Locations: 81
Eligibility criteria
Sporadic or familial ALS diagnosed as clinically possible, probable, lab-support... [+8]
Clinically significant unstable medical condition (other than ALS) that would po... [+8]